Ogilvy to promote Lundbeck's antidepressant drug vortioxetine
Ogilvy's health team has won a global brief to help launch a drug mooted as a 'breakthrough treatment' for depression.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>